J2329 HCPCS code: Injection, ublituximab-xiiy, 1mg
J2329 is the HCPCS Level II code for injection, ublituximab-xiiy, 1mg. In 2024 Medicare paid an average of $48.99 per service for J2329 across 237,436 services. Its Medicare coverage code is C (Carrier judgment): Coverage is decided by the Medicare contractor (MAC) case by case. Medicare volume rose 378% from 2023 to 2024 (49,711 to 237,436 services). In 2024, about 226 clinicians billed Medicare for J2329 for 329 beneficiaries; New York, Florida, Maryland accounted for 38% of services.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | C — Carrier judgment |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | O1E — Other drugs |
| Added | 2023-07-01 |
| Last action effective | 2023-07-01 |
Who bills J2329 (2024)
| Measure | Value |
|---|---|
| Clinicians billing (by place of service) | 226 |
| Medicare beneficiaries | 329 |
| States with claims | 13 |
| Share of services in top 3 states (New York, Florida, Maryland) | 38% |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for J2329, 2023–2024
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2023 | 49,711 | 98 | $62.57 | $49.88 |
| 2024 | 237,436 | 329 | $61.33 | $48.99 |
States with the most J2329 services (2024)
| State | Services | Avg. paid |
|---|---|---|
| New York | 28,352 | $50.08 |
| Florida | 19,500 | $40.47 |
| Maryland | 16,651 | $49.92 |
| Texas | 16,201 | $52.10 |
| Michigan | 13,950 | $53.97 |
What changed for J2329
- 2023-07-01: J2329 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J2329?
J2329 is the HCPCS Level II code for injection, ublituximab-xiiy, 1mg. Short descriptor: "Inj ublituximab-xiiy, 1 mg".
How much does Medicare pay for J2329?
In 2024, the average Medicare payment was $48.99 per service (average allowed $61.33).
Does Medicare cover J2329?
Coverage code C — Carrier judgment. Coverage is decided by the Medicare contractor (MAC) case by case.
Related J23 codes
- J2300 — Injection, nalbuphine hydrochloride, per 10 mg
- J2305 — Injection, nitroglycerin, 5 mg
- J2310 — Injection, naloxone hydrochloride, per 1 mg
- J2311 — Injection, naloxone hydrochloride (zimhi), 1 mg
- J2312 — Injection, naloxone hydrochloride, not otherwise specified, 0.01 mg
- J2313 — Injection, naloxone hydrochloride (zimhi), 0.01 mg
- J2315 — Injection, naltrexone, depot form, 1 mg
- J2320 — Injection, nandrolone decanoate, up to 50 mg
- J2323 — Injection, natalizumab, 1 mg
- J2325 — Injection, nesiritide, 0.1 mg
- J2326 — Injection, nusinersen, 0.1 mg
- J2327 — Injection, risankizumab-rzaa, intravenous, 1 mg
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J2329
- Watch J2329 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J2329
Compiled by Caduvo from public CMS (Medicare) records, HCPCS release October 2026. Fees are Medicare allowables, not commercial rates. Not reviewed or endorsed by CMS. Not billing or legal advice. Report an error. Data and corrections policy.